Evidence map›Paper›PMID 33275872›Full record

ArticleGlobal public health2021

Exploring the evolution of policies for universal antiretroviral therapy and their implementation across three sub-Saharan African countries: Findings from the SHAPE study.

Moses Kumwenda, Morten Skovdal, Alison Wringe, Thoko Kalua, Hadija Kweka, John Songo, Farida Hassan, Rujeko Samanthia Chimukuche, Mosa Moshabela, Janet Seeley and 1 more

Abstract read
In one paragraph

Article in Global public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Moses KumwendaHelse Nord TB Initiative, College of Medicine, University of Malawi, Blantyre, Malawi.ORCID 0000-0003-3091-7330
Morten SkovdalDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.
Alison WringeDepartment of Population Health, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0001-6939-3461
Thoko KaluaDepartment of HIV and AIDS, Ministry of Health, Lilongwe, Malawi.
Hadija KwekaIndependent consultant, Dar es Salaam, United Republic of Tanzania.
John SongoMalawi Epidemiology and Intervention Research Unit, Karonga, Malawi.
Farida HassanIfakara Health Institute, Dar es Salaam, United Republic of Tanzania.
Rujeko Samanthia ChimukucheAfrican Health Research Institute, Durban, South Africa.
Mosa MoshabelaAfrican Health Research Institute, Durban, South Africa.ORCID 0000-0002-9438-7095
Janet SeeleyDepartment of Population Health, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-0583-5272
Jenny RenjuDepartment of Population Health, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0001-5650-1902

Funding

Medical Research Council MR/P014313/1Wellcome Trust
6 · The paper itself

Abstract

Universal antiretroviral therapy (ART) strategies have dramatically changed HIV programming across sub-Saharan Africa. We explored factors that influenced the development, adoption and implementation of universal ART policies in Tanzania, South Africa and Malawi. We conducted 26 key informant interviews and applied Kingdon's 'streams' model to explore how problems, policies and politics converged to provide a window of opportunity for universal ART roll-out. Weak health systems and sub-optimal care retention were raised as

Indexed as

Health PolicyHIV InfectionsHumansPolicy MakingPoliticsSouth Africahealth systemsHIVPolicysub-Saharan AfricaUniversal treatment

Identifiers

PMID33275872
PMCPMC7612916

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.